Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
835.44
835.92
733.07
1,098.00
1,086.39
940.76
1,023.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
835.44
835.92
733.07
1,098.00
1,086.39
940.76
1,023.20
Raw Material Cost
663.37
655.04
595.57
975.72
901.22
742.56
850.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.83
7.29
9.19
9.85
7.82
8.34
7.32
Selling and Distribution Expenses
113.66
122.44
99.82
85.55
120.39
126.97
133.77
Other Expenses
0.59
-0.15
-0.48
0.20
0.64
0.84
1.49
Total Expenditure (Excl Depreciation)
790.72
783.26
699.81
1,073.10
1,035.85
886.25
1,006.34
Operating Profit (PBDIT) excl Other Income
44.699999999999996
52.699999999999996
33.3
24.900000000000002
50.5
54.5
16.9
Other Income
19.67
8.51
8.78
19.18
8.36
11.64
20.42
Operating Profit (PBDIT)
83.82
91.73
64.96
73.61
88.61
96.92
61.89
Interest
7.83
7.29
9.19
9.85
7.82
8.34
7.32
Exceptional Items
-5.85
-0.12
-4.12
2.18
3.63
-4.34
4.63
Gross Profit (PBDT)
172.07
180.88
137.49
122.28
185.17
198.20
172.87
Depreciation
39.88
39.88
40.41
40.41
40.12
40.12
36.36
Profit Before Tax
30.26
44.44
11.23
25.52
44.31
44.12
22.84
Tax
-3.58
8.00
14.64
2.30
6.64
6.79
10.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.28
37.01
-0.87
24.01
38.26
38.02
13.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.28
37.01
-0.87
24.01
38.26
38.02
13.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.44
-0.57
-2.54
-0.79
-0.58
-0.69
-0.97
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.84
36.43
-3.41
23.21
37.67
37.33
12.56
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,162.97
2,182.53
2,104.08
2,101.55
2,094.24
2,063.98
2,019.57
Earnings per share (EPS)
0.07
0.08
-0.0
0.05
0.08
0.08
0.03
Diluted Earnings per share
0.07
0.08
-0.0
0.05
0.08
0.08
0.03
Operating Profit Margin (Excl OI)
2.91%
5.18%
2.15%
1.28%
3.69%
4.8%
0.5%
Gross Profit Margin
8.4%
10.09%
7.04%
6.0%
7.77%
8.95%
5.79%
PAT Margin
4.1%
4.43%
-0.12%
2.19%
3.52%
4.04%
1.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -23.10% vs -8.49% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -10.34% vs -28.05% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -20.05% vs -18.48% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs -3.70% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Anhui Fengyuan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
835.44
0
835.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
835.44
0
835.44
Raw Material Cost
663.37
0
663.37
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.83
0
7.83
Selling and Distribution Expenses
113.66
0
113.66
Other Expenses
0.59
0.00
0.59
Total Expenditure (Excl Depreciation)
790.72
0
790.72
Operating Profit (PBDIT) excl Other Income
44.71
0.00
44.71
Other Income
19.67
0
19.67
Operating Profit (PBDIT)
83.82
0
83.82
Interest
7.83
0
7.83
Exceptional Items
-5.85
0
-5.85
Gross Profit (PBDT)
172.07
0
172.07
Depreciation
39.88
0
39.88
Profit Before Tax
30.26
0
30.26
Tax
-3.58
0
-3.58
Provisions and contingencies
0
0
0.00
Profit After Tax
34.28
0
34.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.28
0
34.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.44
0
-0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.84
0
33.84
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,162.97
0
2,162.97
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
2.91%
0%
0.00
2.91%
Gross Profit Margin
8.40%
0%
0.00
8.40%
PAT Margin
4.10%
0%
0.00
4.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 83.54 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -0.06% vs 14.02% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -23.10% vs -8.49% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.38 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -7.14% vs 1,170.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -10.34% vs -28.05% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.42 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -22.84% vs 48.04% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -20.05% vs -18.48% in Jun 2025
Quarterly - Interest
Interest 0.78 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 6.85% vs -20.65% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs -3.70% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.91%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
